Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.

Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?

Ben Sahra, Issam, Le Marchand-Brustel, Yannick, Tanti, Jean-François, Bost, Frédéric · 2010 · Molecular Cancer Therapeutics

Abstract

Metformin is the most widely used antidiabetic drug in the world, and there is increasing evidence of a potential efficacy of this agent as an anticancer drug. First, epidemiological studies show a decrease in cancer incidence in metformin-treated patients. Second, metformin decreases insulin resistance and indirectly reduces insulin level, a beneficial effect because insulin promotes cancer cell growth. Third, several reports outline a direct inhibitory effect of metformin on cancer cell growth and an antitumoral action. Finally, metformin activates the AMP activated protein kinase (AMPK) pathway, a major sensor of the energetic status of the cell, which has been proposed as a promising therapeutic target in cancer. Mol Cancer Ther; 9(5); 1092–99. ©2010 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/1535-7163.mct-09-1186

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 70 references

Cited by

See all 559

Metadata

Authors
Ben Sahra, I., Le Marchand-Brustel, Y., Tanti, J.-F., & Bost, F.
Affiliations
  • Authors' Affiliations: 1INSERM U895, Team 7: Cellular and Molecular Physiopathology of Obesity and Diabetes, 2Université de Nice-Sophia-Antipolis, UFR Médecine, IFR 50, and 3Centre Hospitalier Universitaire de Nice, Hôpital L'Archet, Pôle digestif, Nice, France
  • Inserm (FR)
Venue
Molecular Cancer Therapeutics
Published
2010-05-01
Volume
9
Issue
5
Pages
1092-1099
ISSN
  • 1535-7163 (ISSN-L)
  • 1538-8514
OpenAlex
W2153980878
Cited by
493
References
70
Citations by year
2026: 9 · 2025: 10 · 2024: 17 · 2023: 17 · 2022: 23 · 2021: 27 · 2020: 16 · 2019: 34 · 2018: 33 · 2017: 40 · 2016: 32 · 2015: 40 · 2014: 61 · 2013: 39 · 2012: 43
FWCI
17.32
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Cancer Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Association pour la Recherche sur le Cancer
  • Centre National de la Recherche Scientifique
  • Association pour la Recherche sur les Tumeurs de la Prostate
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
metformin, anticancer drug repurposing, antidiabetic drugs, cancer incidence, insulin resistance, insulin, tumor cell growth inhibition, AMPK, AMPK signaling, anticancer activity
MeSH terms
Adenylate Kinase, Animals, Antineoplastic Agents, Humans, Hypoglycemic Agents, Medical Oncology, Metformin, Models, Biological, Neoplasms, Protein Serine-Threonine Kinases, Intracellular Signaling Peptides and Proteins, Cell Proliferation, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug? https://app.cochat.ai/papers/10.1158/1535-7163.mct-09-1186
The paper
Ben Sahra, I., Le Marchand-Brustel, Y., Tanti, J.-F., & Bost, F. (2010). Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug? Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-09-1186

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.